A new study offers encouraging news for older adults with chronic respiratory conditions who may struggle to access traditional gym-based rehabilitation programs. Researchers found that pulmonary ...

Artificial intelligence is showing promise in improving the detection and management of idiopathic pulmonary fibrosis (IPF), ...

In its second-quarter earnings release, the company said that in July and August 2025 it analyzed interim data from the ...

Analysts have recently evaluated Liquidia and provided 12-month price targets. The average target is $28.83, accompanied by a ...

Learn more about whether Amneal Pharmaceuticals, Inc. or Liquidia Corporation is a better investment based on AAII's A+ ...

We recently published 10 Stocks on Euphoria. Are You Holding Any? Liquidia Corp. (NASDAQ:LQDA) is one of the best-performing ...

A 28-year-old woman was admitted to the hospital because of severe hypoxemia and right heart failure that had been caused by rapidly progressive pulmonary hypertension. A diagnosis was made.

Shiv Sena(UBT) on Wednesday supported the Supreme Court's orders upholding the Bombay High Court's stay on feeding pigeons ...

Data from ASPEN-06 trial highlights CD47 expression as a key predictive biomarker of greater response to evorpacept in HER2+ Gastric Cancer; updated data to be presented at a medical conference in ...

EMERYVILLE, Calif., Aug. 13, 2025 (GLOBE NEWSWIRE) -- XOMA Royalty Corporation (NASDAQ: XOMA), the biotech royalty aggregator, reported its 2025 second quarter and year to date financial results and ...

Liquidia Technologies ( ($LQDA) ) has released its Q2 earnings. Here is a breakdown of the information Liquidia Technologies presented to its ...